Drawing for RAVETA

USPTO serial 85039197

RAVETA

Reviewed by CopyMark Law Group

Reg. 4244208Status 710
Filing date
Status date
Registration date
Nov 20, 2012
Examiner
TANNER, MICHAEL R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with RAVETA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jerald E. Nagae

JERALD E. NAGAE CHRISTENSEN O'CONNOR JOHNSON KINDNESS PL1201 Third Avenue, Suite 3600Seattle, WA 98101-3029UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of disorders of the nervous system, the cardiovascular system, the respiratory system, the digestive system, the reproductive system, the endocrine system, and the genitourinary system; pharmaceutical preparations for treatment of nephrological disorders, dermatological disorders, hematological disorders, immunological disorders and metabolic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; antibiotics, antifungal preparations, anti-viral preparations; anticoagulants; antithrombotic agents; vaccines for the treatment of infectious diseasesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 21, 2019C8..CANCELLED SEC. 8 (6-YR)—
Nov 20, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 29, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 20, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 17, 2012DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Oct 17, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 16, 2012IUCNNOTICE OF ALLOWANCE CANCELLED—
Oct 16, 2012D1BRTEAS DELETE 1(B) BASIS RECEIVED—
May 29, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 3, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 3, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 16, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2012ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 10, 2011GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 10, 2011GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 10, 2011CNSISUSPENSION INQUIRY WRITTEN—
Feb 2, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 2, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Feb 2, 2011CNSLSUSPENSION LETTER WRITTEN—
Jan 31, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2011PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 18, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2011ALIEASSIGNED TO LIE—
Jan 7, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2010GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 7, 2010GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 7, 2010CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 29, 2010DOCKASSIGNED TO EXAMINER—
May 20, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance